Peptides capable of modulating immune response

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/705 (2006.01) A61K 38/18 (2006.01) A61P 37/06 (2006.01) C07K 14/725 (2006.01) C07K 14/74 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2486545

Provided are peptides capable of inhibiting proliferation of peripheral blood mononuclear cells (PBMCs) derived from HLA class II alpha 2 chain. Furthermore, peptides capable of inhibiting proliferation of peripheral blood mononuclear cells (PBMCs) derived from T-cell immune response cDNA 7 (TIRC7) costimulatory molecule are described. Compositions comprising such peptides and their use for the treatment of immune diseases are provided.

L'invention concerne des peptides capables d'inhiber la prolifération de cellules mononuclées de sang périphérique (PBMC) dérivées de la chaîne alpha 2 de classe II du système HLA. Elle se rapporte aussi à des peptides capables d'inhiber la prolifération de cellules mononuclées de sang périphérique (PBMC) dérivées de la molécule costimulatrice d'un ADNc 7 à réponse immunitaire spécifique aux lymphocyte T (TIRC7). Cette invention porte également sur des compositions contenant ces peptides et sur leur utilisation dans le traitement de maladies immunitaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptides capable of modulating immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides capable of modulating immune response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides capable of modulating immune response will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1666834

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.